Trade Ideas February 11, 2026

Buy the AI Connectivity Sprint — Ride Hypergrowth, Trim Before Optical Headwinds

Credo (CRDO) looks like a momentum buy for the next several weeks — lofty multiples justify discipline and a tight stop.

By Marcus Reed CRDO
Buy the AI Connectivity Sprint — Ride Hypergrowth, Trim Before Optical Headwinds
CRDO

Credo is printing hypergrowth as hyperscalers load AI racks. Recent results and guidance show revenue and margin expansion; valuation is rich but market appetite for AI connectivity remains strong. This trade targets near-term upside while acknowledging a probable optical-cycle reset later in the year.

Key Points

  • Credo reported revenue up ~272% YoY to $268M with net income of ~$82.6M and free cash flow of $143.6M — growth is real and cash-generative.
  • Valuation is rich: P/E ~115x and P/S ~30x; the stock requires continued execution to sustain multiples.
  • Technicals show short-term support near the 10-day SMA (~$117.8) and neutral RSI; MACD indicates early bullish momentum.
  • Trade plan: Long entry $125.00, stop $110.00, target $195.00, horizon mid term (45 trading days).

Hook & Thesis

Credo Technology (CRDO) is in a rare position: product-led hypergrowth in the heart of the AI data center spend cycle, paired with a valuation that demands near-term execution. The snapshot is simple — the company reported a recent quarter with revenue up roughly triple year-over-year to $268 million and returned to profitability with about $82.6 million in net income, and the market has rewarded that thesis. You can buy the move and ride a continued build in AI racks, but you must plan to exit or hedge before optical module inventories and next-cycle optical pricing create headwinds.

This trade idea is tactical: get long to capture the next wave of data-center demand and positive sentiment, then re-evaluate around the next set of optical-market signals. The numbers support momentum, the technicals show a mixed-but-recovering setup, and the short-interest profile suggests squeezable liquidity — but the valuation is extreme, so keep stops tight.

What Credo Does and Why It Matters

Credo develops connectivity silicon and active electrical cables for data infrastructure — integrated circuits, SerDes chiplets and high-speed connectivity gear that bridges compute racks to optical modules and switches. In plain terms: when hyperscalers and AI customers need to move ever-larger blocks of data at lower latency, Credo’s chips and cable solutions sit in that critical link.

The market cares because AI infrastructure is a multi-year growth runway. As models scale, hyperscalers invest in denser racks, new interconnect architectures, and higher-bandwidth SerDes. Credo is benefiting now: management reported a quarter where revenue grew 272% year-over-year to $268 million and net income rebounded to roughly $82.6 million — clear evidence demand has moved from promise to monetization.

Read the Tape - What the Data Says

  • Price & Market Cap: Current price sits around $127.70. Market capitalization on the snapshot comes in roughly $27.9 billion.
  • Profitability & Cash: The company returned to profitability in the recent quarter and reported free cash flow of $143.6 million on the reporting period referenced. Reported EPS in the snapshot period is roughly $1.17.
  • Valuation: Trailing/forward multiples are elevated. Price-to-earnings sits above 100 (roughly 114-118x in the data), price-to-sales is over 30x, and EV/EBITDA is north of 100x. These are premium multiples that price in sustained rapid growth.
  • Technicals & Flow: Short interest is meaningful but not extreme (several million shares, days-to-cover around 1.2-1.8 historically). The 10-day SMA is about $117.8, 20-day is ~$129.1, 50-day near $143.9; RSI is neutral (~48) and MACD is showing early bullish momentum.
  • Range: The 52-week range is wide — low near $29.09 and a high of $213.80 — reflecting extreme sentiment swings as the stock moved from deep-value to momentum name.

Valuation Framing - Why Rich Multiples Can Still Work (Short Term)

On surface valuation metrics look demanding: P/E ~115x and P/S ~30x. But consider the growth context: management just posted a quarter where revenue roughly tripled year-over-year to $268M and margins expanded as net profit grew to ~$82.6M. In fast-growing, high-margin infrastructure pockets, investors often pay upfront for expected scale. Credo’s free cash flow of roughly $143.6M gives the bull case some foundation — growth is being converted into cash today, not only promised on spreadsheets.

That said, this is not a buy-and-forget name at these multiples. The market will punish any signs that optical module cycles or customer inventory digestion slow the cadence. The trade here is to own the next several weeks to months of momentum, not to argue it should trade at these multiples indefinitely without concrete long-term visibility.

Catalysts (What Gets This Trade Working)

  • Continued AI rack deployments and capacity orders from hyperscalers that keep sequential revenue growth elevated for another quarter or two.
  • Positive forward guidance and margin commentary on the next earnings release, which would validate the recent profit expansion and lift sentiment.
  • Analyst and institutional attention — several brokers and the Street have been upgrading small/mid-cap connectivity names; further upgrades or raised price targets could re-rate the stock.
  • Product ramps for SerDes chiplets or new active electrical cable designs deployed commercially at scale, driving stickier revenue.

Trade Plan - Actionable Setup

Trade Direction: Long

Entry Price: $125.00

Stop Loss: $110.00

Target Price: $195.00

Horizon: mid term (45 trading days) - This trade is designed to capture continued AI infrastructure orders and positive earnings-guidance momentum over the next one to two months. If the stock approaches the target earlier on a surge of positive news, trim or take profits. If the trade is still constructive into the 45-day mark with fresh upside catalysts, you can reassess and roll targets out cautiously.

Rationale: Entry below current market price aims to catch a pullback into short-term support (10-day SMA ~$117.8 and intraday low near $119.38 are reference points). Stop at $110 protects capital if momentum fails and technical support breaks, and target $195 is a disciplined objective that captures a partial move toward prior analyst targets and the name’s longer-term highs without asking for a full re-rating into unsustainably high multiples.

Risks & Counterarguments

At least four material risks to watch:

  • Optical-cycle headwinds: The core counterargument to buying a connectivity stock here is that optical transceiver and module cycles can drive sudden demand swings and price pressure. If hyperscalers take a pause to digest inventory, Credo’s shipment cadence could slow and margins could compress.
  • Valuation sensitivity: With a P/E north of 100 and P/S above 30, the stock is vulnerable to any guidance miss. A single quarter of slower revenue growth or a margin slip could trigger a sharp multiple contraction.
  • Customer concentration: If a handful of hyperscalers account for most spending, any change in a top client’s procurement cadence is a material business risk.
  • Competition & execution: Large incumbents and other emerging connectivity vendors could pressure pricing or win design slots. Execution risk around new product ramps is non-trivial in a complex hardware business.
  • Macro & liquidity: Broader market rotations away from high-multiple tech, or liquidity shocks in small/mid-cap semiconductors, could amplify downside regardless of company performance.

Counterargument to the Trade Thesis

One could reasonably argue that the market has already priced in several quarters of growth, and that Credo’s multiples are too rich to justify the trade. If the optical market softens in the next 60-90 days, the stock could reprice dramatically lower even if Credo posts decent numbers. That is a fair point — it’s precisely why this idea sets a clear stop and targets a mid-term window rather than buying for indefinite appreciation.

Why I Still Prefer a Tactical Long

Even with the counterargument in play, the evidence of cash-generative growth today plus positive analyst attention and active short volume create an asymmetric setup in the near term. The company is not purely promise; it is converting orders into cash and positive earnings. The trade buys that story while limiting exposure to a later optical reset.

What Would Change My Mind

I would abandon this trade and move to neutral or short if any of the following occur:

  • Management issues guidance showing sequential revenue decline or a material margin contraction.
  • Free cash flow turns negative and material inventory build is disclosed tied to canceled orders.
  • Evidence of customer pull-ins/push-outs from hyperscalers suggesting a durable slowdown in AI-capacity buying.
  • Technical breakdown through $110 on strong volume that confirms loss of momentum.

Final Thought

Credo is a classic high-reward, high-risk momentum trade: buy exposure to an active, cash-positive growth story that’s winning in AI connectivity, but use strict risk control because the stock’s valuation and the optical cycle make it fragile. If you’re comfortable managing the stop and treating this as a tactical mid-term swing (45 trading days), the risk/reward can be attractive. If you can’t stomach a downside similar in magnitude to the last deep drawdown, this should not be a core position.

Trade plan snapshot - Long CRDO: Enter $125.00; Stop $110.00; Target $195.00; Horizon: mid term (45 trading days).

Published 02/11/2026

Risks

  • Optical-module and transceiver cycles could cause sudden demand and pricing weakness, compressing Credo’s margins.
  • Extreme valuation sensitivity: with P/E above 100, any guidance miss could trigger sharp multiple contraction.
  • Customer concentration risk — changes in hyperscaler procurement cadence can materially affect revenue.
  • Execution and competition risk from larger incumbents or rival connectivity vendors winning share or pushing prices down.

More from Trade Ideas

Coupang: Data-Breach Fallout Is Not Over - A Short Trade with a 180-Day Horizon Feb 20, 2026 Buy the Dip: Upgrading AMD for a Mid-Term Rebound Feb 20, 2026 Buy the DNOW Dip: MRC Integration Noise Creates a Tactical Entry Feb 20, 2026 Accendra Health: Deleveraging Makes the Risk/Reward Attractive Again Feb 20, 2026 Babcock & Wilcox: A Practical Play on Fast-Deploy Power for AI Data Centers Feb 20, 2026